Literature DB >> 1720381

Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes.

R J Whitley1.   

Abstract

Herpes simplex virus (HSV) infections are among the most commonly encountered in humans. Fortunately, the resulting diseases are more usually nuisances, such as recurrent fever blisters, rather than life threatening or morbidity inducing. Nevertheless, HSV can result in disease of the central nervous system (CNS) with attendant neurological complications. Examples of the latter include herpes simplex encephalitis (HSE) or neonatal HSV infection. The past decade has witnessed significant advances in our understanding of the pathogenesis of these 2 forms of disease and, even more importantly, their amenability to treatment. This review summarises our current understanding of the natural history, pathogenesis, presentation, and treatment of HSV infections of the CNS. Because of the life-threatening nature of herpes simplex infections of the CNS, particular attention is paid to clinical presentation and differential diagnosis of confounding entities which mimic herpes simplex encephalitis. The controversy of brain biopsy versus alternative noninvasive diagnostic procedures is discussed. Clinical presentation and, importantly, the lack of uniform clinical presentation, as well as the value of intervention with appropriate antiviral drugs such as aciclovir and vidarabine (adenine arabinoside, ara-A), are stressed. The clinical outcome of herpes simplex virus infections of the CNS with therapy is particularly relevant. In spite of early intervention with selective and specific inhibitors of viral replication, return to normal function is not always achieved. At the conclusion of this review, the reader should be aware of the potential value of therapy as well as the problems encountered with diagnosis and management of patients with herpes simplex virus infections of the CNS.

Entities:  

Mesh:

Year:  1991        PMID: 1720381     DOI: 10.2165/00003495-199142030-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  108 in total

1.  Central nervous system syndromes of "vital" etiology. A study of 713 cases.

Authors:  H M MEYER; R T JOHNSON; I P CRAWFORD; H E DASCOMB; N G ROGERS
Journal:  Am J Med       Date:  1960-08       Impact factor: 4.965

2.  Experimental herpes simplex encephalitis. Electroencephalographic, clinical, virologic, and pathologic observations in the rabbit.

Authors:  J F Griffith; S Kibrick; P R Dodge; E P Richardson
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1967-09

3.  Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.

Authors:  R Whitley; A D Lakeman; A Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

4.  Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery.

Authors:  D A Hardy; A M Arvin; L L Yasukawa; R N Bronzan; D M Lewinsohn; P A Hensleigh; C G Prober
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

5.  A distinctive clinical EEG profile in herpes simplex encephalitis.

Authors:  J B Smith; B F Westmoreland; T J Reagan; B A Sandok
Journal:  Mayo Clin Proc       Date:  1975-08       Impact factor: 7.616

6.  Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group.

Authors:  S J Soong; N E Watson; G R Caddell; C A Alford; R J Whitley
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

Review 7.  Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications.

Authors:  J W Gnann; N H Barton; R J Whitley
Journal:  Pharmacotherapy       Date:  1983 Sep-Oct       Impact factor: 4.705

8.  Detection of HSV-1 genome in central nervous system of latently infected mice.

Authors:  D L Rock; N W Fraser
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

Review 9.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

10.  Biopsy histopathology in herpes simplex encephalitis and in encephalitis of undefined etiology.

Authors:  J Booss; J H Kim
Journal:  Yale J Biol Med       Date:  1984 Sep-Oct
View more
  19 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies.

Authors:  Debra C Quenelle; Bernhardt Lampert; Deborah J Collins; Terri L Rice; George R Painter; Earl R Kern
Journal:  J Infect Dis       Date:  2010-10-05       Impact factor: 5.226

3.  Spatiotemporal changes of the herpes simplex virus entry receptor nectin-1 in murine brain during postnatal development.

Authors:  Szatmár Horváth; Emese Prandovszky; Zsolt Kis; Claude Krummenacher; Roselyn J Eisenberg; Gary H Cohen; Zoltán Janka; József Toldi
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

4.  The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c mice.

Authors:  Clinton Jones; Melissa Inman; Weiping Peng; Gail Henderson; Alan Doster; Guey-Chuen Perng; Anisa Kaenjak Angeletti
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing.

Authors:  Xianzhi Jiang; Aziz Alami Chentoufi; Chinhui Hsiang; Dale Carpenter; Nelson Osorio; Lbachir BenMohamed; Nigel W Fraser; Clinton Jones; Steven L Wechsler
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  Anders Hjalmarsson; Fredrik Granath; Marianne Forsgren; Maria Brytting; Paul Blomqvist; Birgit Sköldenberg
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

7.  Identification of a novel herpes simplex virus type 1 transcript and protein (AL3) expressed during latency.

Authors:  Tareq Jaber; Gail Henderson; Sumin Li; Guey-Chuen Perng; Dale Carpenter; Steven L Wechsler; Clinton Jones
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

8.  In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.

Authors:  Hui-Wen Yao; Pin Ling; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

Review 9.  Treatment options for the pharmacological therapy of neonatal meningitis.

Authors:  C M Paap; J A Bosso
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

10.  Tranylcypromine reduces herpes simplex virus 1 infection in mice.

Authors:  Hui-Wen Yao; Pin-Hung Lin; Fang-Hsiu Shen; Guey-Chuen Perng; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.